Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia
- PMID: 16002743
- DOI: 10.1161/01.ATV.0000176191.64314.07
Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia
Abstract
Objective: Individuals with familial hypobetalipoproteinemia (FHBL) have been reported to be prone to fatty liver disease (FLD). Conversely, the profound reduction of low-density lipoprotein (LDL) cholesterol in this disorder might decrease cardiovascular risk. In the present study, we assessed hepatic steatosis as well as noninvasive surrogate markers for cardiovascular disease (CVD) in subjects with FHBL and in matched controls.
Methods and results: Hepatic steatosis was assessed by abdominal ultrasonography. Carotid intima-media thickness (IMT) and distal common carotid arterial wall stiffness as surrogate markers for CVD risk were measured using high-resolution B-mode ultrasonography. Whereas transaminase levels were only modestly elevated, both prevalence (54% versus 29%; P=0.01) and severity of steatosis were significantly higher in FHBL individuals compared with controls. Despite similar IMT measurements, arterial stiffness was significantly lower in FHBL (P=0.04) compared with controls. Additionally, the increase in arterial stiffness as seen in the presence of traditional risk factors was attenuated, suggesting that very low levels of apoB-containing lipoproteins can negate the adverse effects of other risk factors on the vasculature.
Conclusions: FHBL is characterized by an increased prevalence and severity of fatty liver disease. The observed decreased level of arterial wall stiffness, most pronounced in the presence of nonlipid risk factors, is indicative of cardiovascular protection in these subjects.
Similar articles
-
Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.Clin Chim Acta. 2009 Jan;399(1-2):64-8. doi: 10.1016/j.cca.2008.09.021. Epub 2008 Sep 24. Clin Chim Acta. 2009. PMID: 18848826
-
Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.Metabolism. 2005 May;54(5):682-8. doi: 10.1016/j.metabol.2004.12.013. Metabolism. 2005. PMID: 15877300
-
Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.Ann Hepatol. 2011 Apr-Jun;10(2):155-64. Ann Hepatol. 2011. PMID: 21502677
-
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.Acta Diabetol. 2017 Feb;54(2):111-122. doi: 10.1007/s00592-016-0931-4. Epub 2016 Nov 2. Acta Diabetol. 2017. PMID: 27804036 Review.
-
Familial hypobetalipoproteinemia: genetics and metabolism.Cell Mol Life Sci. 2005 Jun;62(12):1372-8. doi: 10.1007/s00018-005-4473-0. Cell Mol Life Sci. 2005. PMID: 15818469 Free PMC article. Review.
Cited by
-
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?Intern Emerg Med. 2009 Feb;4(1):71-3. doi: 10.1007/s11739-008-0178-3. Epub 2008 Jul 17. Intern Emerg Med. 2009. PMID: 18633688 No abstract available.
-
Does inhibition of apolipoprotein B synthesis produce foie gras?J Lipid Res. 2010 May;51(5):877-8. doi: 10.1194/jlr.E005140. Epub 2009 Dec 30. J Lipid Res. 2010. PMID: 20042543 Free PMC article. No abstract available.
-
Common and rare gene variants affecting plasma LDL cholesterol.Clin Biochem Rev. 2008 Feb;29(1):11-26. Clin Biochem Rev. 2008. PMID: 18566665 Free PMC article.
-
Low LDL-C: Is It all Good News?Curr Atheroscler Rep. 2024 Dec;26(12):673-681. doi: 10.1007/s11883-024-01238-y. Epub 2024 Sep 10. Curr Atheroscler Rep. 2024. PMID: 39254830 Review.
-
Genetics of lipid traits and relationship to coronary artery disease.Curr Cardiol Rep. 2013 Sep;15(9):396. doi: 10.1007/s11886-013-0396-9. Curr Cardiol Rep. 2013. PMID: 23881580 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous